In North America and Europe, return-to-work (RTW) rates vary among breast cancer (BC) survivors, from 24% to 66% and from 53% to 82% at 6 and 36 months after diagnosis, respectively. To date, there is a lack of data on RTW rates after BC diagnosis in Latin America. Therefore, the primary objectives of this study were to define RTW rates at 12 and 24 months after BC diagnosis and to identify the factors associated with RTW in this population. METHODS: In total, 125 employed women from a single institution with newly diagnosed BC were interviewed by telephone at 6, 12, and 24 months after diagnosis. Those who had inoperable or metastatic disease were excluded. RESULTS: Overall, RTW rates were 30.3% and 60.4% at 12 and 24 months after BC diagnosis, respectively. Most women reported that they received support from their employer, but only 29.1% reported having been offered work adjustments. In multivariate analysis, the factors associated with positive RTW outcomes included higher household income (odds ratio [OR], 17.76; 95% confidence interval [CI], 3.33-94.75; P = .001), breast-conserving surgery (OR, 9.77; 95% CI, 2.03-47.05; P = .004), and work adjustments (OR, 37.62; 95% CI, 2.03-47.05; P = .004). The factors associated with negative RTW outcomes included adjuvant endocrine therapy (OR, 0.11; 95% CI, 0.02-0.74; P = .023), and depression diagnosed after BC (OR, 0.07; 95% CI, 0.01-0.63; P = .017). CONCLUSIONS: RTW rates in the current study were lower than those observed in developed countries but similar to the rates among low-income Americans. Workplace adjustments, higher income, breast-conserving surgery, endocrine therapy, and depression after BC played an important role in the RTW decision. Cancer 2018;124:4700-4710.
INTRODUCTION
Breast cancer (BC) is a highly prevalent disease and is the most common cancer in women worldwide. Incidence trends vary with ethnicity, BC subtype, and national socioeconomic status. 1, 2 When assessing the risk of developing BC up to age 75 years, it is reported that patients from North America (10%), compared with South America (5.6%) and Central America (3.5%), have a greater cumulative risk. 3 Conversely, the incidence of BC among younger women (aged <44 years) is greater in Latin America compared with that in North America (20% vs 12%). 4 Advances in BC screening, 5 knowledge of disease biology, 6 and treatment improvements 7 have resulted in better survival outcomes and an increase in BC survivors. In 2002, there were 8 million cancer survivors worldwide, of whom 22% were BC survivors. By 2022, it is estimated that this number will be close to 18 million. 8 In Brazil, the 5-year survival rate has increased from 78% (in 1995-1999) to 87% (in 2005-2009) 9 ; and, by 2012, more than 1 million adults had survived cancer for 5 years (based on 5-year prevalence data). Of these, 23% had been diagnosed with BC. 10 Considering the numbers of BC survivors, it is necessary to gain a better understanding of their medical and psychosocial needs. An important aspect related to well being and quality of life (QOL) among BC survivors is the possibility of returning to work after diagnosis and completion of therapy. Absenteeism during the period of cancer treatment is common, because patients have to adjust to their new routine. Clinical appointments, treatment-related side effects, as well as family and work duties must be reconciled. A large, population-based study conducted in the Netherlands demonstrated that women with BC had a 60% greater risk of losing their job and a 100% greater chance of receiving social security benefits for >10 years. 11 Because work can be inherently rewarding and an important source of income, loss of work can affect QOL as well as family budget and the ability to afford the ongoing cancer treatment. 12, 13 Returning to work also can symbolize a return to normality and social reintegration.
14 Therefore, as suggested by Steiner et al, understanding the long-term effects of a
Cancer December 15, 2018 cancer diagnosis and its treatment on employment status should be a critical focus of cancer survivor research. 15 In Central and South America, there are very few reports on the frequency or pattern of resumption of work among patients with cancer. Also, there is scarce information on the factors involved in work rehabilitation. To address this gap in knowledge, we undertook a prospective, longitudinal study of women who were receiving treatment for BC at a tertiary referral hospital in Brazil. Our objectives were to identify the return-to-work (RTW) rates in the first 2 years after BC diagnosis and to identify the factors that might influence outcomes in this population.
MATERIALS AND METHODS

Eligibility Criteria
Employed, Portuguese-speaking women aged 18 to 57 with a diagnosis of locoregional BC (invasive or in situ carcinoma) who were enrolled in the BC clinic of the Instituto do Cancer do Estado de Sao Paulo (ICESP) were identified from the eletronic database system after their first visit to the clinic. Inaugurated in 2008, ICESP was created as a social health organization by Sao Paulo's state government in partnership with the Faculty of Medicine of the University of Sao Paulo, with the objective of establishing one of the largest public hospitals specialized in cancer treatment in Latin America, serving exclusively uninsured patients from the National Health System. Participants were required to be ≤5 months postdiagnosis. They could be receiving current treatment or may have undergone treatment with curative intent, and they had to be cognitively able to participate. Ineligibility criteria included metastatic disease (because this population may present symptoms that affect RTW), a previous cancer diagnosis, pregnancy or <12 months postpartum, and previous retirement.
Recruitment and Study Participants
This prospective cohort study started in July 2012. Patients initially were invited to participate through an invitation letter in conjunction with the informed consent form (ICF). The letter had a stamped return envelope. This approach resulted in very low recruitment rates (mostly because patients would not return the envelope). Consequently, an amendment was made in May 2013, and patients started being invited on their second visit to the clinic by a study investigator. Between July 2012 and September 2014, 723 eligible women were invited to participate, and 125 agreed to take part in the study. The vast majority of the screening patients failed to return the ICF because of the logistical burden of returning it by mail (this information was collected by telephone). Among the participants, as a result of disease progression, 2 patients died before the first study interview, and 2 others were excluded because of inability to contact them. Of 121 women in the analysis, 8 had BC relapse and were excluded from the study. In addition, 2 other Cancer December 15, 2018 patients had changed their address (1 moved to another state, and the other moved to another country); in both cases telephone contact was not updated (Fig. 1) . The Institutional Review Board (IRB) of the University of Sao Paulo approved this study. ICFs were obtained from all participants before study enrollment.
Most screened patients were excluded because of age ≥57 years, as depicted in Figure 1 . In Brazil, women can retire at age 60. Because the follow-up duration of the current study was 2 years, retirement would represent a bias.
Data Collection
Patients were interviewed by telephone at 6, 12, and 24 months after BC diagnosis. The surveys collected data on demographic characteristics, employment status, health status, comorbidity, job type, support from employers and life partners, weight gain, pain (at primary breast surgery site, ipsilateral arm, or both), and lymphedema. Patients were asked about employer accommodation for cancer treatment needs and perceived employer discrimination against them because of cancer diagnosis. Data on cancer stage and treatment were extracted from the electronic medical records. In addition, at each telephone contact, patients filled the QOL questionnaire Functional Assessment of Cancer Therapy-Breast (FACT-B).
Study Variables
The main study outcome was self-reported employment status at 6, 12, and 24 months after BC diagnosis. We defined the primary outcome as either part-time or fulltime employment. A full-time job was defined as ≥35 hours of work per week, and a part-time job was defined as <35 hours per week. RTW was chosen as the primary outcome because we considered it a key measure of recovery for BC survivors. Variables that were evaluated included type of occupation, hours of work per week, self-employment, previous employment absence because of medical leave, perceived employer accommodation, and discrimination. In addition, patients were asked about employer and life-partner support. Except for type of occupation and hours of work per week, all other variables were categorical (yes/no). Monthly family income was measured according to the minimum wage received (in Brazil, the minimum wage was set to a value of approximately $239.00 US per month).
Education was classified as no instruction/incomplete elementary school, complete elementary school/ high school incomplete, completed high school or some college, and completed college or a postgraduate degree.
Family structure was evaluated using 3 parameters: married/partnered versus not married/partnered, number of children, and children aged <18 years living at home.
QOL was assessed at 6, 12, and 24 months after diagnosis using the FACT-B questionnaire. 16 Clinical variables included cancer stage, immunohistochemistry, cancer-directed treatment (chemotherapy, radiotherapy, endocrine therapy, and antihuman epidermal growth factor receptor 2 [anti-HER2] therapy), comorbidity, and type of breast surgery (mastectomy or breast-conserving surgery [BCS]). Also, breast reconstruction and contralateral breast symmetry procedures were evaluated. This information was collected from electronic medical records and supplemented by patient report.
Statistical Analysis
Eligible patients were sequentially included. The variables were categorized as either qualitative or quantitative. In case of missing data, variables were treated through listwise deletion, and models for analyses were constructed only using patients who had complete data.
Evaluations of the factors related to RTW at 12 and 24 months were performed using the Pearson chi-square (or Fisher exact) test. For multivariate analyses, odds ratios (ORs) with their respective 95% confidence intervals (95% CIs) were calculated. Construction of the final model for the factors related to RTW at 24 months was performed using a stepwise forward method, in which variables with P values < .2 in the unadjusted model were considered as candidate variables for the multiple model. Finally, variables that were identified by the unadjusted model as independent factors associated with RTW at 24 months (P < .05) were retained in the final model. The level of significance was 5%. Analyses were performed using the statistical software package SPSS version 18.0 (IBM Corporation, Armonk, NY) and Stata version 11.0 (StataCorp, College Station, TX).
The sample size was defined by estimating a population proportion. 17 Because the estimated proportion of patients who RTW is 45% at 18 months, based on subgroup of Latin American women on Blinder et al study, 18 with a 95% CI [±10%] of 35% to 55%, an initial sample of 96 patients was calculated. Estimating that 30% would be lost to follow-up, the final sample calculation was set at 125 patients. More than 90% of patients received chemotherapy, 53.6% in the neoadjuvant setting. Among the patients who received adjuvant chemotherapy, the average interval between surgery and the time to chemotherapy initiation was 1.7 months (±1.0 months). Anthracycline combined with a taxane was the most common regimen used. Among patients who had HER2-positive BC, all received trastuzumab. The median time between diagnosis and any treatment initiation of was 2.3 months (range, 0.0-7.9 months). Tamoxifen was the initial endocrine therapy for 81.3% of patients who had HR-positive BC. Adjuvant radiotherapy was received by 83.5% of patients. Radiotherapy fields are presented in Table 1 .
RESULTS
Socioeconomic Data
Before BC diagnosis, 81% of patients had a full-time job. Among them, 59.5% reported that they were their family's main source of household income, and only 14.9% were self-employed. The majority of patients enjoyed their work activity and received support from their employer after they were diagnosed with BC. Only 29.1% of women reported having been offered some type of adjustment in their work. Sixteen patients (13.4%) confirmed sick leave periods before the cancer diagnosis (for reasons other than cancer). Partner support was reported by almost all partnered patients. Approximately 80% of patients were low-income individuals (with less than 4 Cancer December 15, 2018 times the minimum wage per month per family). Job types are listed in Table 2 .
Return to Work Rates
RTW rates after BC diagnosis, as measured at 6, 12, and 24 months, are illustrated in Figure 2 . The median length of leave was 13.3 months (range, 2-24 months).
Perceived employer discrimination was reported by 10.7% of the women at 24 months. In addition, 55% reported weight gain, with a median weight gain of 6 kg (range, 2-30 kg). Among patients who were married or partnered at diagnosis, 5 were divorced at the 2-year follow-up. Twenty-one percent of patients reported a reduction in their monthly household income. Among the 67 women who were working 24 months after diagnosis, 11.9% reduced their workload from full-time to parttime, whereas 3% increased their workload from parttime to full-time.
Univariate Analysis of Characteristics Associated With Employment Status at 24 Months
Factors that had a statistically significant association with higher RTW rates at 24 months after BC diagnosis were: higher education level, perception of general health status as good/very good, employer support, and job accommodation. Compared with these data, patients who underwent mastectomy, who were diagnosed with postcancer depression, or who experienced pain returned significantly less often to their work activities (Table 3) .
Multivariate Analysis of Characteristics Associated With Being Employed 24 Months After Diagnosis
In the multivariate analysis of factors associated with being employed 24 months after diagnosis, employer accommodation had the most positive impact on RTW (OR, 37.62; 95% CI, 2.03-47.05; P = .004). Household income ≥2 times the minimum wage also was associated with better RTW rates (OR, 17.76; 95% CI, 3.33-94.75; P = .001). BCS, compared with mastectomy (regardless of breast reconstruction or breast symmetry procedures), also was associated with higher rates of RTW (OR, 9.77; 95% CI, 2.03-47.05; P = .004). Being diagnosed with depression after BC diagnosis reduced RTW rates (OR, 0.07; 95% CI, 0.01-0.63; P = .017), as did receipt of adjuvant endocrine therapy (OR, 0.11; 95% CI, 0.02-0.74; P = .023) ( Table 4) .
Quality of Life and Return to Work
A significant increase in QOL was observed between months 6 and 24, in the FACT-B Trial Outcome Index (TOI). This was related specifically to aspects of health (Supporting Table 1 ). When the means of each of these questionnaires (FACT-B TOI, FACT-General [FACT-G], and FACT-B total) were correlated at the 6-month, 12-month, and 24-month marks, significantly higher QOL scores were observed for the patients who returned to work (Table 5) . DISCUSSION BC management has improved substantially over the past years, resulting in a growing population of working age women who are BC survivors. The current study elucidates important aspects associated with QOL and RTW after BC diagnosis.
RTW rates reported in our study were lower than those observed in developed countries. [18] [19] [20] [21] [22] [23] Indeed, the Cancer December 15, 2018 rates reported by Blinder et al, who evaluated RTW rates among low-income and limited-resource US women with BC who had different ethnic backgrounds, are in line with those observed in the current study, in which most patients also had low incomes. 18 On the basis of these findings, it appears that low-income women, regardless of their nationality, may take longer to RTW and do so at lower rates than higher income women.
In both Brazil and the United States, employers are enforced by law to protect workers' rights and maintain their job. To achieve this, some adjustments may be necessary. 24, 25 In reality, the capacity to accommodate workers' treatment needs is an important factor in patients' ability to RTW. This finding also was reported previously, reinforcing the need to adapt workers' functions and demands during cancer therapy. 20, 26 Employer discrimination was reported by 10% of the women. There was no significant association between this factor and lower rates of RTW failure. In the literature, these data are conflicting and require further investigation. Nevertheless, this important aspect of a worker's relationship with their employer could be biased, because the reports of discrimination, as well as job adjustment, were evaluated exclusively according to patient's perception.
Some studies have demonstrated an inversely proportional correlation between older age and lower RTW rates. 19, 23, 27, 28 In our patient population, there was also a similar trend, when comparing patients aged ≤50 versus >50 years, but this difference was not statistically significant.
In agreement with previous studies, we observed a correlation between higher education and household income levels with higher RTW rates. In general, educational level 18, 28, 29 and higher income 11, 27, 29, 30 were closely associated. Patients with lower educational levels are more likely to be involved with manual and/or loaded tasks jobs, which could explain their lower RTW rates. In addition, higher education levels may be associated with more intellectual jobs, better chances of career development, and even better opportunities to adapt work activities. In addition, most of these patients must resume work if they want to maintain their standard of living.
To our knowledge, the association between depression after BC and lower rates of RTW has not been reported previously, probably because previous studies did not investigate this specific aspect of cancer survivorship and focused only on toxicities related to the cancer treatment.
Self-assessment of general health at 6 months was another important item. It is noteworthy that the overall health status of the participants was measured according to their perception, which is a subjective assessment. Early in treatment, women who rated their overall health status as good or very good had higher rates of RTW compared with those who rated their overall health status as bad or very poor. It is important to mention that all patients had nonmetastatic BC and a good performance status, so that any attempt to correlate self-defined health status with performance status and comorbidities would be unfeasible in this population.
Similar to previous studies, mastectomy and pain development had a negative impact on RTW rates. 11, 23, 29 Conversely, chemotherapy, radiotherapy, and axillar dissection were not associated with lower RTW rates, contrary to previous publications. 27 Anti-HER2 therapy, as previously reported by Hoyer et al, Cancer December 15, 2018 had no impact in RTW rates. 23 In line with our current findings, Lee and colleagues observed that adjuvant endocrine therapy was associated with lower rates of RTW. 31 Many factors may have contributed to this finding, such as the occurrence of endocrine therapy-related events (fatigue, hot flashes, and arthralgia, among others). The literature reports conflicting results regarding this topic, because many other trials did not observe such an association. 20, 21, 30 QOL and work productivity have a bidirectional correlation. 18, 23, 32 Improved QOL correlates with greater capacity to work, whereas work improves the quality of psychosocial life. Additional factors, such as household income, also interfere in QOL among cancer survivors, a factor not entirely related to the effect of health on income. In the current study, better QOL at 6, 12, and 24 months were predictors of RTW 2 years after diagnosis, reinforcing this important correlation. A limitation of our study is the finding that patients who were included in our analysis came exclusively from a single cancer center. Lower patient heterogeneity and lack of external validity are among the major problems and biases generated by single-center trials. Nevertheless, our cohort represents the majority of patients in Brazil, in which 72% of the population has no medical health care plan and are treated through the National Health System. 33 Currently, the ICESP has nearly 40,000 National Health System patients undergoing treatment and receives approximately 900 new patients every month.
Another limitation of this study may include the participants' demographic and clinical characteristics, which might not fully match those among patients who did not agree to participate or did not return the ICF. Because this comparison was not previously planned, we did not obtain consent to collect the demographic and clinical characteristics in the electronic medical records of screen-failure patients. However, the study population is likely representative of the global cohort of women with BC who receive treatment at Brazilian National Health System Cancer December 15, 2018 institutions. Recently, Renna Junior et al retrospectively analyzed more than 170,000 uninsured women with BC in Brazil, including 51% white women, 48% partnered women, 7% women with a college or higher education level, and 41% with stage II disease. 34 These data are in alignment with patient sociodemographic characteristics in the current study, except for educational levels. Women in our study had higher levels of schooling (23% had a college degree with or without a postgraduate degree). We cannot rule out the Cancer December 15, 2018 possibility that minor differences like this may have had some impact on our results. In a growing scenario of productive-age survivors of BC who are disease-free, gaining insight into the frequency of RTW and the factors associated with this outcome, in different treatment scenarios and among women with varied socioeconomic status, is essential to achieve better patient care. The current study highlights the importance of the employer's role in the recovery of employed patients with BC. In addition, higher financial income, type of BC surgery, and workplace accommodation appear to be key factors associated with an increased likelihood of RTW. The data reported provide meaningful insights into survivorship issues that could affect treatment outcomes. Ultimately, identifying patients who likely will experience greater difficulties with RTW hopefully will trigger the development of strategies with a focus on assisting patients with the work-rehabilitation process.
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